N/a
-Jul 14 2020: Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia
-SPY pattern: Runner
-Intraday pattern: Consolidation
-Other notes: Also notes of Bowl and Bull flag intraday price action
Strategy: First test long of 4.4
Confluence: N/a
Strike Zone: 4.4 - 4.3
Sizing (lots + emergency): 1+1
Risk (stop / Rs): Hold below 4.3
Was holding below 4.3 so had to stop out, took smaller loss thanks to emergency add
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-07-14 14:36:20 | RIGL | buy | $4.360 | long |
2020-07-14 14:36:21 | RIGL | buy | $4.360 | long |
2020-07-14 14:37:57 | RIGL | buy | $4.240 | long |
2020-07-14 14:39:51 | RIGL | sell | $4.260 | long |
2020-07-14 14:40:22 | RIGL | sell | $4.280 | long |
2020-07-14 14:40:22 | RIGL | sell | $4.280 | long |
2020-07-14 14:40:22 | RIGL | sell | $4.282 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!